| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2017-09-09 02:54:25 UTC |
|---|
| Update Date | 2022-11-30 19:25:56 UTC |
|---|
| HMDB ID | HMDB0114857 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | PA(16:1(9Z)/18:3(6Z,9Z,12Z)) |
|---|
| Description | PA(16:1(9Z)/18:3(6Z,9Z,12Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(16:1(9Z)/18:3(6Z,9Z,12Z)), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of gamma-linolenic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids. |
|---|
| Structure | [H][C@@](COC(=O)CCCCCCC\C=C/CCCCCC)(COP(O)(O)=O)OC(=O)CCCC\C=C/C\C=C/C\C=C/CCCCC InChI=1S/C37H65O8P/c1-3-5-7-9-11-13-15-17-18-20-22-24-26-28-30-32-37(39)45-35(34-44-46(40,41)42)33-43-36(38)31-29-27-25-23-21-19-16-14-12-10-8-6-4-2/h11,13-14,16-18,22,24,35H,3-10,12,15,19-21,23,25-34H2,1-2H3,(H2,40,41,42)/b13-11-,16-14-,18-17-,24-22-/t35-/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| 1-Palmitoleoyl-2-gamma-linolenoyl-sn-glycero-3-phosphate | HMDB | | 1-Palmitoleoyl-2-gamma-linolenoyl-sn-phosphatidic acid | HMDB | | PA(16:1/18:3) | HMDB | | PA(16:1N7/18:3N6) | HMDB | | PA(16:1W7/18:3W6) | HMDB | | PA(34:4) | HMDB | | Phosphatidic acid(16:1(9Z)/18:3(6Z,9Z,12Z)) | HMDB | | Phosphatidic acid(16:1/18:3) | HMDB | | Phosphatidic acid(16:1n7/18:3n6) | HMDB | | Phosphatidic acid(16:1W7/18:3W6) | HMDB | | Phosphatidic acid(34:4) | HMDB | | Phosphatidate(16:1(9Z)/18:3(6Z,9Z,12Z)) | HMDB | | Phosphatidate(16:1/18:3) | HMDB | | Phosphatidate(16:1N7/18:3N6) | HMDB | | Phosphatidate(16:1W7/18:3W6) | HMDB | | Phosphatidate(34:4) | HMDB | | 1-palmitoleoyl-2-gamma-linolenoyl-sn-glycero-3-phosphate | SMPDB, HMDB | | 1-palmitoleoyl-2-gamma-linolenoyl-sn-phosphatidic acid | SMPDB, HMDB | | PA(16:1/18:3) | SMPDB, HMDB | | PA(16:1n7/18:3n6) | SMPDB, HMDB | | PA(16:1w7/18:3w6) | SMPDB, HMDB | | PA(34:4) | SMPDB, HMDB | | Phosphatidic acid(16:1(9Z)/18:3(6Z,9Z,12Z)) | SMPDB, HMDB | | Phosphatidic acid(16:1/18:3) | SMPDB, HMDB | | Phosphatidic acid(16:1n7/18:3n6) | SMPDB, HMDB | | Phosphatidic acid(16:1w7/18:3w6) | SMPDB, HMDB | | Phosphatidic acid(34:4) | SMPDB, HMDB | | Phosphatidate(16:1(9Z)/18:3(6Z,9Z,12Z)) | SMPDB, HMDB | | Phosphatidate(16:1/18:3) | SMPDB, HMDB | | Phosphatidate(16:1n7/18:3n6) | SMPDB, HMDB | | Phosphatidate(16:1w7/18:3w6) | SMPDB, HMDB | | PA(16:1(9Z)/18:3(6Z,9Z,12Z)) | SMPDB |
|
|---|
| Chemical Formula | C37H65O8P |
|---|
| Average Molecular Weight | 668.893 |
|---|
| Monoisotopic Molecular Weight | 668.441706051 |
|---|
| IUPAC Name | [(2R)-3-[(9Z)-hexadec-9-enoyloxy]-2-[(6Z,9Z,12Z)-octadeca-6,9,12-trienoyloxy]propoxy]phosphonic acid |
|---|
| Traditional Name | (2R)-3-[(9Z)-hexadec-9-enoyloxy]-2-[(6Z,9Z,12Z)-octadeca-6,9,12-trienoyloxy]propoxyphosphonic acid |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | [H][C@@](COC(=O)CCCCCCC\C=C/CCCCCC)(COP(O)(O)=O)OC(=O)CCCC\C=C/C\C=C/C\C=C/CCCCC |
|---|
| InChI Identifier | InChI=1S/C37H65O8P/c1-3-5-7-9-11-13-15-17-18-20-22-24-26-28-30-32-37(39)45-35(34-44-46(40,41)42)33-43-36(38)31-29-27-25-23-21-19-16-14-12-10-8-6-4-2/h11,13-14,16-18,22,24,35H,3-10,12,15,19-21,23,25-34H2,1-2H3,(H2,40,41,42)/b13-11-,16-14-,18-17-,24-22-/t35-/m1/s1 |
|---|
| InChI Key | JYOCUILAZUIHCV-ZKAVACCVSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as 1,2-diacylglycerol-3-phosphates. These are glycerol-3-phosphates in which the glycerol moiety is bonded to two aliphatic chains through ester linkages. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Glycerophospholipids |
|---|
| Sub Class | Glycerophosphates |
|---|
| Direct Parent | 1,2-diacylglycerol-3-phosphates |
|---|
| Alternative Parents | |
|---|
| Substituents | - 1,2-diacylglycerol-3-phosphate
- Fatty acid ester
- Monoalkyl phosphate
- Dicarboxylic acid or derivatives
- Fatty acyl
- Alkyl phosphate
- Phosphoric acid ester
- Organic phosphoric acid derivative
- Carboxylic acid ester
- Carboxylic acid derivative
- Hydrocarbon derivative
- Organic oxide
- Organic oxygen compound
- Carbonyl group
- Organooxygen compound
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Naturally occurring processBiological processBiochemical pathwayMetabolic pathway- De Novo Triacylglycerol Biosynthesis TG(16:1(9Z)/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)) (PathBank: SMP0065587)
- De Novo Triacylglycerol Biosynthesis TG(16:1(9Z)/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)) (PathBank: SMP0065588)
- De Novo Triacylglycerol Biosynthesis TG(16:1(9Z)/18:3(6Z,9Z,12Z)/20:2(11Z,14Z)) (PathBank: SMP0065592)
- De Novo Triacylglycerol Biosynthesis TG(16:1(9Z)/18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0065596)
- De Novo Triacylglycerol Biosynthesis TG(16:1(9Z)/18:3(6Z,9Z,12Z)/20:0) (PathBank: SMP0074340)
- De Novo Triacylglycerol Biosynthesis TG(16:1(9Z)/18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)) (PathBank: SMP0074343)
- De Novo Triacylglycerol Biosynthesis TG(16:1(9Z)/18:3(6Z,9Z,12Z)/22:2(13Z,16Z)) (PathBank: SMP0074350)
- De Novo Triacylglycerol Biosynthesis TG(16:1(9Z)/18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z)) (PathBank: SMP0074352)
- De Novo Triacylglycerol Biosynthesis TG(16:1(9Z)/18:3(6Z,9Z,12Z)/18:4(6Z,9Z,12Z,15Z)) (PathBank: SMP0089602)
- De Novo Triacylglycerol Biosynthesis TG(16:1(9Z)/18:3(6Z,9Z,12Z)/20:1(11Z)) (PathBank: SMP0089604)
- De Novo Triacylglycerol Biosynthesis TG(16:1(9Z)/18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0089608)
- De Novo Triacylglycerol Biosynthesis TG(16:1(9Z)/18:3(6Z,9Z,12Z)/22:0) (PathBank: SMP0089611)
- De Novo Triacylglycerol Biosynthesis TG(16:1(9Z)/18:3(6Z,9Z,12Z)/22:1(13Z)) (PathBank: SMP0089612)
- De Novo Triacylglycerol Biosynthesis TG(16:1(9Z)/18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0065597)
- De Novo Triacylglycerol Biosynthesis TG(16:1(9Z)/18:3(6Z,9Z,12Z)/24:1(15Z)) (PathBank: SMP0065606)
- De Novo Triacylglycerol Biosynthesis TG(16:1(9Z)/18:3(6Z,9Z,12Z)/20:3(8Z,11Z,14Z)) (PathBank: SMP0089607)
- De Novo Triacylglycerol Biosynthesis TG(16:1(9Z)/18:3(6Z,9Z,12Z)/24:0) (PathBank: SMP0089618)
- De Novo Triacylglycerol Biosynthesis TG(16:1(9Z)/18:3(6Z,9Z,12Z)/22:4(7Z,10Z,13Z,16Z)) (PathBank: SMP0065601)
- De Novo Triacylglycerol Biosynthesis TG(16:1(9Z)/18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0065603)
- De Novo Triacylglycerol Biosynthesis TG(16:1(9Z)/18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0089617)
- De Novo Triacylglycerol Biosynthesis TG(16:1(9Z)/18:3(6Z,9Z,12Z)/16:1(9Z)) (PathBank: SMP0021457)
- De Novo Triacylglycerol Biosynthesis TG(16:1(9Z)/18:3(6Z,9Z,12Z)/18:1(11Z)) (PathBank: SMP0021458)
- De Novo Triacylglycerol Biosynthesis TG(16:1(9Z)/18:3(6Z,9Z,12Z)/18:1(9Z)) (PathBank: SMP0021459)
- De Novo Triacylglycerol Biosynthesis TG(16:1(9Z)/18:3(6Z,9Z,12Z)/18:2(9Z,12Z)) (PathBank: SMP0021464)
- Cardiolipin Biosynthesis CL(16:1(9Z)/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)) (PathBank: SMP0084254)
- Cardiolipin Biosynthesis CL(16:1(9Z)/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)) (PathBank: SMP0084255)
- Cardiolipin Biosynthesis CL(16:1(9Z)/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)/20:0) (PathBank: SMP0084256)
- Cardiolipin Biosynthesis CL(16:1(9Z)/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)) (PathBank: SMP0084257)
- Cardiolipin Biosynthesis CL(16:1(9Z)/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)/20:3(8Z,11Z,14Z)) (PathBank: SMP0084258)
- Cardiolipin Biosynthesis CL(16:1(9Z)/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0084259)
- Cardiolipin Biosynthesis CL(16:1(9Z)/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0084260)
- Cardiolipin Biosynthesis CL(16:1(9Z)/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0084261)
- Cardiolipin Biosynthesis CL(16:1(9Z)/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)) (PathBank: SMP0084262)
- Cardiolipin Biosynthesis CL(16:1(9Z)/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:0) (PathBank: SMP0084263)
- Cardiolipin Biosynthesis CL(16:1(9Z)/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z)) (PathBank: SMP0084264)
- Cardiolipin Biosynthesis CL(16:1(9Z)/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:3(8Z,11Z,14Z)) (PathBank: SMP0084265)
- Cardiolipin Biosynthesis CL(16:1(9Z)/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0084266)
- Cardiolipin Biosynthesis CL(16:1(9Z)/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0084267)
- Cardiolipin Biosynthesis CL(16:1(9Z)/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0084268)
- Cardiolipin Biosynthesis CL(16:1(9Z)/18:3(6Z,9Z,12Z)/20:0/20:0) (PathBank: SMP0084269)
- Cardiolipin Biosynthesis CL(16:1(9Z)/18:3(6Z,9Z,12Z)/20:0/20:3(5Z,8Z,11Z)) (PathBank: SMP0084270)
- Cardiolipin Biosynthesis CL(16:1(9Z)/18:3(6Z,9Z,12Z)/20:0/20:3(8Z,11Z,14Z)) (PathBank: SMP0084272)
- Cardiolipin Biosynthesis CL(16:1(9Z)/18:3(6Z,9Z,12Z)/20:0/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0084273)
- Cardiolipin Biosynthesis CL(16:1(9Z)/18:3(6Z,9Z,12Z)/20:0/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0084274)
- Cardiolipin Biosynthesis CL(16:1(9Z)/18:3(6Z,9Z,12Z)/20:0/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0084275)
- Cardiolipin Biosynthesis CL(16:1(9Z)/18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z)) (PathBank: SMP0084276)
- Cardiolipin Biosynthesis CL(16:1(9Z)/18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z)) (PathBank: SMP0084277)
- Cardiolipin Biosynthesis CL(16:1(9Z)/18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0084278)
- Cardiolipin Biosynthesis CL(16:1(9Z)/18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0084279)
- Cardiolipin Biosynthesis CL(16:1(9Z)/18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0084280)
- Cardiolipin Biosynthesis CL(16:1(9Z)/18:3(6Z,9Z,12Z)/20:3(8Z,11Z,14Z)/20:3(8Z,11Z,14Z)) (PathBank: SMP0084281)
- Cardiolipin Biosynthesis CL(16:1(9Z)/18:3(6Z,9Z,12Z)/20:3(8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0084282)
- Cardiolipin Biosynthesis CL(16:1(9Z)/18:3(6Z,9Z,12Z)/20:3(8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0084283)
- Cardiolipin Biosynthesis CL(16:1(9Z)/18:3(6Z,9Z,12Z)/20:3(8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0084284)
- Cardiolipin Biosynthesis CL(16:1(9Z)/18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0084285)
- Cardiolipin Biosynthesis CL(16:1(9Z)/18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0084286)
- Cardiolipin Biosynthesis CL(16:1(9Z)/18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0084287)
- Cardiolipin Biosynthesis CL(16:1(9Z)/18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0084288)
- Cardiolipin Biosynthesis CL(16:1(9Z)/18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0084289)
- Cardiolipin Biosynthesis CL(16:1(9Z)/18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0084290)
|
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. | 7.68 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 31.6866 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.94 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 4799.7 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 415.6 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 310.1 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 248.2 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 1051.2 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 1710.8 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 1075.5 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 239.8 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 3259.3 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 1101.4 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 2602.8 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 1214.7 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 676.7 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 418.6 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 778.1 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 10.3 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| PA(16:1(9Z)/18:3(6Z,9Z,12Z)),1TMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\CCCCC(=O)O[C@H](COC(=O)CCCCCCC/C=C\CCCCCC)COP(=O)(O)O[Si](C)(C)C | 4729.6 | Semi standard non polar | 33892256 | | PA(16:1(9Z)/18:3(6Z,9Z,12Z)),1TMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\CCCCC(=O)O[C@H](COC(=O)CCCCCCC/C=C\CCCCCC)COP(=O)(O)O[Si](C)(C)C | 4189.1 | Standard non polar | 33892256 | | PA(16:1(9Z)/18:3(6Z,9Z,12Z)),1TMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\CCCCC(=O)O[C@H](COC(=O)CCCCCCC/C=C\CCCCCC)COP(=O)(O)O[Si](C)(C)C | 5308.2 | Standard polar | 33892256 | | PA(16:1(9Z)/18:3(6Z,9Z,12Z)),2TMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\CCCCC(=O)O[C@H](COC(=O)CCCCCCC/C=C\CCCCCC)COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C | 4698.8 | Semi standard non polar | 33892256 | | PA(16:1(9Z)/18:3(6Z,9Z,12Z)),2TMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\CCCCC(=O)O[C@H](COC(=O)CCCCCCC/C=C\CCCCCC)COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C | 4155.1 | Standard non polar | 33892256 | | PA(16:1(9Z)/18:3(6Z,9Z,12Z)),2TMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\CCCCC(=O)O[C@H](COC(=O)CCCCCCC/C=C\CCCCCC)COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C | 4572.0 | Standard polar | 33892256 | | PA(16:1(9Z)/18:3(6Z,9Z,12Z)),1TBDMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\CCCCC(=O)O[C@H](COC(=O)CCCCCCC/C=C\CCCCCC)COP(=O)(O)O[Si](C)(C)C(C)(C)C | 4949.0 | Semi standard non polar | 33892256 | | PA(16:1(9Z)/18:3(6Z,9Z,12Z)),1TBDMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\CCCCC(=O)O[C@H](COC(=O)CCCCCCC/C=C\CCCCCC)COP(=O)(O)O[Si](C)(C)C(C)(C)C | 4301.5 | Standard non polar | 33892256 | | PA(16:1(9Z)/18:3(6Z,9Z,12Z)),1TBDMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\CCCCC(=O)O[C@H](COC(=O)CCCCCCC/C=C\CCCCCC)COP(=O)(O)O[Si](C)(C)C(C)(C)C | 5299.4 | Standard polar | 33892256 | | PA(16:1(9Z)/18:3(6Z,9Z,12Z)),2TBDMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\CCCCC(=O)O[C@H](COC(=O)CCCCCCC/C=C\CCCCCC)COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 5122.7 | Semi standard non polar | 33892256 | | PA(16:1(9Z)/18:3(6Z,9Z,12Z)),2TBDMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\CCCCC(=O)O[C@H](COC(=O)CCCCCCC/C=C\CCCCCC)COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 4327.1 | Standard non polar | 33892256 | | PA(16:1(9Z)/18:3(6Z,9Z,12Z)),2TBDMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\CCCCC(=O)O[C@H](COC(=O)CCCCCCC/C=C\CCCCCC)COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 4671.7 | Standard polar | 33892256 |
|
|---|